Having this in mind, the main outcome of this study was to assess whether GCKR rs780094 was associated with the histological features of liver damage in patients with biopsy-proven NAFLD, after correction for PNPLA3 genotype. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.